vTv Therapeutics (NASDAQ: VTVT) maintains a total market capitalization fluctuating around $131 million USD. This micro-to-small-cap valuation reflects current investor sentiment regarding its clinical drug pipeline, cash reserves, equity dilution history, and the probability of future commercial success across its metabolic and autoimmune therapeutics programs.